Edition:
India

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

14.14USD
16 Feb 2018
Change (% chg)

$-0.64 (-4.33%)
Prev Close
$14.78
Open
$14.71
Day's High
$14.79
Day's Low
$13.97
Volume
90,837
Avg. Vol
127,783
52-wk High
$20.25
52-wk Low
$8.60

Chart for

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $894.46
Shares Outstanding(Mil.): 47.15
Dividend: --
Yield (%): --

Financials

BRIEF-Akebia Therapeutics Gives Update On Vadadustat Development Program

* AKEBIA THERAPEUTICS PROVIDES UPDATE ON VADADUSTAT DEVELOPMENT PROGRAM

12 Feb 2018

BRIEF-Akebia Therapeutics reports Q3 loss per share $0.49

* Akebia Therapeutics announces third quarter 2017 financial results

09 Nov 2017

BRIEF-Invirsa secures seed financing to develop new approach

* Invirsa secures seed financing to develop new approach to treating common infectious diseases that affect millions annually Source text for Eikon: Further company coverage:

07 Nov 2017

Insider trading suspect out of U.S. jail as judge weighs 'Jekyll & Hyde' risk

BOSTON, Oct 12 A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge's concern that the man's "Dr. Jekyll and Mr. Hyde" tendencies could lead him to violate his bail conditions.

13 Oct 2017

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON, Sept 22 A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.

23 Sep 2017

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $183.55 -0.05
Johnson & Johnson (JNJ.N) $133.15 +1.92
Roche Holding Ltd. (ROG.S) CHF225.50 +2.10
Roche Holding Ltd. (RO.S) CHF230.20 +2.60
FibroGen Inc (FGEN.OQ) $56.50 +0.05
AstraZeneca plc (AZN.L) 4,739.50 +26.00
Astellas Pharma Inc (4503.T) ¥1,486 --
GlaxoSmithKline plc (GSK.L) 1,318.60 +18.20
Bayer AG (BAYGn.DE) €98.54 +1.15
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates